Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe

The launch is preceded by an exclusive licensing agreement for Pliaglis^® with Canadian dermatology company Crescita Therapeutics Inc. (“Crescita”). The agreement grants Croma the exclusive rights to commercialize Pliaglis in nine countries including Germany, Ireland, Switzerland, Belgium, Luxembourg, the UK and Netherlands and Brazil.